How to Choose the Right Protein Quantitation Assay | LC-MS, ELISA & MSD Compared
Emery Pharma at PDA West Coast’s Quality Ball
Parenteral Drug Association (PDA) Networking & panel discussion on CMC challenges at Emery Pharma
There’s no Perfect Molecule as a Drug: Lessons from the Avacopan (Tavneos) Drug Development
PBSS & Emery Pharma Host Landmark LC-MS Training Workshop for Bay Area Biotech Scientists
Pipetting Tips for Precision & Accuracy for Method Development & Validation
Emery Pharma Antimicrobial Testing | MIC, MBC, MFC, MBEC & Resistance Profiling Experts
Webinar: Nitrosamines in Medicines: Hidden Risks & How to Prevent Them
Restoring Rifampin: Fortrea & Emery Pharma’s Partnership for Safer DDI Studies & Nitrosamine Testing
What You Need to Know About Pharmaceutical Stability Testing
Drug Metabolism: ADME, Metabolite ID, Mass Spectrometry Techniques at Emery Pharma
Psychoplastogens: Next-Gen Neurotherapeutics Transforming Mental Health and Brain Plasticity
Podcast series: Why Obesity Isn’t the Real Problem-Dr. Robert Lustig Exposes the Truth About Chronic Disease
Podcast series: Top Bioanalysis Questions Answered: LC-MS/MS, PK/PD, Orbitrap, ADA, NMR & More
Podcast series: Revolutionizing Antibiotic Testing: MIC, MBC & Time-Kill Assays
Podcast series: QQQ vs. HRMS, choosing the best Mass Spec for Impurity Testing
Podcast series: Antibody Drug Conjugates (ADCs) – Revolutionizing Cancer Treatment
Speaker series: Simplifying Clinical Pharmacokinetics with Professor Leslie Benet
QQQ vs HRMS: Which Mass Spec Wins for Impurity Quantitation? Emery Pharma’s Bridging Study Reveals
Fighting Fentanyl with Naloxone: A lifeline Amid the Epidemic
Podcast series: GLP-1 agonist like Ozempic, Tirzepatide, Wegovy, and more
LC-MS/MS Method to Quantify Small Molecules in Surrogate Matrix, Validated by ICH M10
Empowering Youth: Boys & Girls Club of Alameda Visits Emery Pharma for Science and Sustainability
LC-MS/MS Method for Quantitation of Each Monoclonal Antibody in a 6-Component Antibody Cocktail
Genetic Toxicology & Carcinogenicity: Insights on Drug Safety, Mutation Risks, and Cancer Risk
CAR-T Revolution – Advancing Lymphoma Treatment with Precision & Innovation
Fructose: The Hidden Fat Factory - Uncovering the Link to Obesity and Fatty Liver
Dr. Robert Lustig: Can you exercise your way out of a bad diet?
Hypothesizing on how Nitrosamine Drug Substance Related Impurities (NDSRI's) are being formed?
IP Considerations Relating To Antibody Drug Conjugates (ADC)
Dr. Robert Lustig Interview-Vitamin D, Ketogenic Diets & Personal Responsibility
Breast Cancer Screening: Enhancing diagnosis with FDA-cleared ATUSA(R) an AI-driven 3D ultrasound.
Analytical Biochemistry Strategy for Gene Therapy Drug Development
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
Antibody Drug Conjugate (ADC) and DAR determination
Ligand Binding Assay (LBA) and Bioanalysis
Gas Chromatography Uncovered: Theory Meets Application
Assuring Excellence! Inside the Role of QA Director in Contract Research Organization
Advancing Cancer Precision:: ADC Breakthroughs & DAR Characterization Insights
Robert Lustig, MD - Everything You Knew About Obesity is Wrong! Personal Responsibility / Public Health
Unveiling Glycan Mysteries: LC-MS Insights into Biologics' PTM Impact & Analysis
Robert Lustig, MD - WARNING - Ultra Processed Foods Fueling Mental and Neurological Disorders
Prof. Leslie Benet - UCSF: The explanation for WHY when bioavailability calculation exceed unity?
Richard Johnson, MD, Sweet Connections: Unveiling Sugar's Role in Obesity, Diabetes, and Alzheimer's
Dr. Mark Szabo: NMR Spectroscopy. Challenges in Structure Determination, Thermodynamics, & Kinetics
Dr. Bill Wilson, Full Presentation to Emery Pharma Team on his recognition of CARB syndrome.
Richard Johnson, MD: Emery Pharma Speakers series: Role of Sugar in Obesity, Diabetes, and Alzheimer
Robert Lustig, MD "Fatty Liver, Sugar, Metabolic Syndrome, & Ozempic"
Robert Lustig Presentation - Food, Metabolism, and Psychiatric Disease
Bioanalytical Method Validation vs. Analytical Method Validation
New Psychoactive Substances (NPS)
Biological Carbon Capture (Day or Night)
NAFLD — The Big Picture
Bioanalytical Method Validation of a Small Molecule in a Surrogate Matrix by LC-MS/MS
Robert Lustig, MD "Hateful-Grateful 8" a conversation with Ron Najafi
Hydroxy Radical Protein Footprinting (HRPF) and its relevance in Drug Development
Oncology Drug Modalities: A New Era in Oncology Drug Development
Psychedelics and Related Plasticity - Promoting Neurotherapeutics
Universal Immunity: Why people don’t generate broad spectrum responses to mutating viruses
Glycan Analysis Overview
Learn about Intact Mass and Subunit Analyses of a Therapeutic Antibody by Hi Res Orbitrap Mass Spec
Elucidating and Translating The Role of Glycans in Health and Diseases
The Subcellular Processes That Belie All Chronic Disease
cGMP NMR Capabilities
LC-MS Peptide Mapping
Medicinal and Synthetic Chemistry Services Overview
EFSA FEEDAP Guidance Presentation
Poloxamer detection used in applications of gene therapy and delivery
Ranitidine stability study
Nuclear Magnetic Resonance (NMR) Spectroscopy Overview
Liquid Chromatography/Mass Spectroscopy (LC-MS) Overview
Minimum Inhibitory Concentration (MIC) Assay Overview
Biofilm Profiling Services – Minimal Biofilm Eradicating Concentration (MBEC)
Testing Antimicrobial Activity and Cytotoxicity of Wound Care and Skin Cleanser
NMR Services Analysis
Testing Antimicrobial & Preservative Effectiveness
Webinar: Nitrosamines in Medicines: Hidden Risks & How to Prevent Them
Restoring Rifampin: Fortrea & Emery Pharma’s Partnership for Safer DDI Studies & Nitrosamine Testing
What You Need to Know About Pharmaceutical Stability Testing
Drug Metabolism: ADME, Metabolite ID, Mass Spectrometry Techniques at Emery Pharma
Psychoplastogens: Next-Gen Neurotherapeutics Transforming Mental Health and Brain Plasticity
Podcast series: Why Obesity Isn’t the Real Problem-Dr. Robert Lustig Exposes the Truth About Chronic Disease
Podcast series: Top Bioanalysis Questions Answered: LC-MS/MS, PK/PD, Orbitrap, ADA, NMR & More
Podcast series: Revolutionizing Antibiotic Testing: MIC, MBC & Time-Kill Assays
Podcast series: QQQ vs. HRMS, choosing the best Mass Spec for Impurity Testing
Podcast series: Antibody Drug Conjugates (ADCs) – Revolutionizing Cancer Treatment
Speaker series: Simplifying Clinical Pharmacokinetics with Professor Leslie Benet
QQQ vs HRMS: Which Mass Spec Wins for Impurity Quantitation? Emery Pharma’s Bridging Study Reveals
Fighting Fentanyl with Naloxone: A lifeline Amid the Epidemic
Podcast series: GLP-1 agonist like Ozempic, Tirzepatide, Wegovy, and more
LC-MS/MS Method to Quantify Small Molecules in Surrogate Matrix, Validated by ICH M10
Empowering Youth: Boys & Girls Club of Alameda Visits Emery Pharma for Science and Sustainability
LC-MS/MS Method for Quantitation of Each Monoclonal Antibody in a 6-Component Antibody Cocktail
Genetic Toxicology & Carcinogenicity: Insights on Drug Safety, Mutation Risks, and Cancer Risk
CAR-T Revolution – Advancing Lymphoma Treatment with Precision & Innovation
Fructose: The Hidden Fat Factory - Uncovering the Link to Obesity and Fatty Liver
Dr. Robert Lustig: Can you exercise your way out of a bad diet?
Hypothesizing on how Nitrosamine Drug Substance Related Impurities (NDSRI's) are being formed?
IP Considerations Relating To Antibody Drug Conjugates (ADC)
Dr. Robert Lustig Interview-Vitamin D, Ketogenic Diets & Personal Responsibility
Breast Cancer Screening: Enhancing diagnosis with FDA-cleared ATUSA(R) an AI-driven 3D ultrasound.
Analytical Biochemistry Strategy for Gene Therapy Drug Development
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
Antibody Drug Conjugate (ADC) and DAR determination
Ligand Binding Assay (LBA) and Bioanalysis
Gas Chromatography Uncovered: Theory Meets Application
Assuring Excellence! Inside the Role of QA Director in Contract Research Organization
Advancing Cancer Precision:: ADC Breakthroughs & DAR Characterization Insights
Robert Lustig, MD - Everything You Knew About Obesity is Wrong! Personal Responsibility / Public Health
Unveiling Glycan Mysteries: LC-MS Insights into Biologics' PTM Impact & Analysis
Robert Lustig, MD - WARNING - Ultra Processed Foods Fueling Mental and Neurological Disorders
Prof. Leslie Benet - UCSF: The explanation for WHY when bioavailability calculation exceed unity?
Richard Johnson, MD, Sweet Connections: Unveiling Sugar's Role in Obesity, Diabetes, and Alzheimer's
Dr. Mark Szabo: NMR Spectroscopy. Challenges in Structure Determination, Thermodynamics, & Kinetics
Dr. Bill Wilson, Full Presentation to Emery Pharma Team on his recognition of CARB syndrome.
Richard Johnson, MD: Emery Pharma Speakers series: Role of Sugar in Obesity, Diabetes, and Alzheimer
Robert Lustig, MD "Fatty Liver, Sugar, Metabolic Syndrome, & Ozempic"
Robert Lustig Presentation - Food, Metabolism, and Psychiatric Disease
Bioanalytical Method Validation vs. Analytical Method Validation
New Psychoactive Substances (NPS)
Biological Carbon Capture (Day or Night)
NAFLD — The Big Picture
Bioanalytical Method Validation of a Small Molecule in a Surrogate Matrix by LC-MS/MS
Robert Lustig, MD "Hateful-Grateful 8" a conversation with Ron Najafi
Hydroxy Radical Protein Footprinting (HRPF) and its relevance in Drug Development
Oncology Drug Modalities: A New Era in Oncology Drug Development
Psychedelics and Related Plasticity - Promoting Neurotherapeutics
Universal Immunity: Why people don’t generate broad spectrum responses to mutating viruses
Glycan Analysis Overview
Learn about Intact Mass and Subunit Analyses of a Therapeutic Antibody by Hi Res Orbitrap Mass Spec
Elucidating and Translating The Role of Glycans in Health and Diseases
The Subcellular Processes That Belie All Chronic Disease
cGMP NMR Capabilities
LC-MS Peptide Mapping
Medicinal and Synthetic Chemistry Services Overview
EFSA FEEDAP Guidance Presentation
Poloxamer detection used in applications of gene therapy and delivery
Ranitidine stability study
Nuclear Magnetic Resonance (NMR) Spectroscopy Overview
Liquid Chromatography/Mass Spectroscopy (LC-MS) Overview
Minimum Inhibitory Concentration (MIC) Assay Overview
Biofilm Profiling Services – Minimal Biofilm Eradicating Concentration (MBEC)
Testing Antimicrobial Activity and Cytotoxicity of Wound Care and Skin Cleanser
NMR Services Analysis
Testing Antimicrobial & Preservative Effectiveness